Chemical Immobilization for Polar Bears
The polar bear (Ursus maritimus) is found throughout the Arctic region. These animals travel long distances over vast expanses, often on drifting oceanic ice floes, searching for seals, their primary prey. Polar bears are stocky in build, with a long neck, relatively small head, short, rounded ears, and a short tail. Males, which are much larger than females, weigh in at 410 to 720 kg (900 to 1,600 pounds), and are around 1.6 meters (5.3 feet) tall at the shoulder and 2.2–2.5 meters in length. With the exception of one subspecies of grizzly bear, the polar bear is the largest and most powerful land carnivore.1 The polar bear has no natural predators and knows no fear of humans.
Polar bear mating occurs in Spring, and implantation of the fertilized ovum is delayed. Including the delay, gestation may last 195–265 days, and one to four cubs are born during the winter in a den of ice or snow. Cubs weigh less than 1 kg at birth and are not weaned until after they are two years old.2 Young polar bears are routinely killed by unrelated adult males; for this reason, female polar bears are extremely defensive of their cubs when adult males are present. The young usually remain with their mothers until they reach sexual maturity, with females first reproducing at four to eight years of age. The males mature at about the same age as females but do not breed until a few years later. Longevity in the wild is approximately 25 to 30 years, but polar bears in captivity have lived to more than 35 years old.1
Polar Bears: Populations and Predation
Through the 1950s and 1960s, there was a marked increase in recorded numbers of polar bears being killed for their hides, giving rise to world-wide concern that the species might be endangered. At a meeting in Fairbanks, Alaska 1965, representatives of circumpolar arctic nations discussed conservation of polar bears and concluded that international coordination of research and management efforts was essential.3 By 2020, an estimated 22,000 to 31,000 polar bears were living in the wild.
Polar bears are an ice-dependent species that rely on sea ice as a platform to hunt ice seals and to raise their young. They are generally solitary and completely carnivorous, feeding mostly on ringed seals, but also on bearded seals and other pinnipeds. The bear stalks seals resting on the ice, ambushes them near breathing holes, and digs young seals from snow shelters where they are born.3 Polar bears prefer ice that is subject to periodic fracturing by wind and sea currents, because these fractures offer seals access to both air and water. As their prey is aquatic, polar bears are excellent swimmers, and they are even known to kill beluga whales.2 Polar bears are opportunistic as well as predatory: They will consume dead fish and carcasses of stranded whales and eat garbage near human settlements. The latter often puts them at odds with human populations, occasionally requiring the intervention of wildlife managers.
Chemical Immobilization and Formulations
The capture and handling of free-ranging polar bears is an important tool for wildlife research, conservation, and management. However, live capture can expose individual animals to risk of injury or mortality. The polar bear is a species that has generated an abundance of concern amongst conservationists throughout its range due to climate change and shrinking habitats. While field studies using less-invasive methods such as aerial surveys can provide insights into polar bear populations, the physical capture, marking, and recapture of individual animals remains an important approach for population assessment. Additionally, live capture is sometimes the only means of collecting certain types of biological samples, measurements, and information on reproduction, age structure, and survival rates.2 Regardless of the reasons for live capture, the immobilization and restraint of individual bears entails some risk.
In the mid-1980s, a mixture of the dissociative anesthetic tiletamine hydrochloride and the tranquilizer zolazepam hydrochloride (ZT) emerged as the preferred drug for immobilizing free-ranging polar bears.4 Available under the trade names Telazol and Zoletil, this formulation has several advantages, including full immobilization with a single injection (dart), a wide tolerance to overdosing, effective partial immobilization upon underdosing, maintenance of high respiratory rates that allow bears to thermoregulate while immobilized and a mortality rate of less than 1 in 1,000 captures.4,5
In 1981, Lee et. al. reported using a concentrated solution of 200 mg Ketamine HCl and 200 mg xylazine HCl/ml for the immobilization of free-ranging polar bears. “A mean dosage of 6.8 mg of each drug/kg body weight was successful in immobilizing polar bears older than one year and 2.8 mg of each drug/kg body weight was effective for cubs. Male and female polar bears responded similarly to the drugs. Immobilization was characterized by slow, deep breathing, relaxed muscles, no excess salivation and no convulsions. The combination of ketamine and xylazine appears to be a useful alternative to drugs previously used for immobilizing polar bears.”5
As above, the Handbook of Wildlife Chemical Immobilization (Arnemo & Kreeger, 2018) recommends tiletamine hydrochloride and zolazepam hydrochloride at a dosage of 8 mg/kg for polar bears. This may be supplemented with ketamine at 2 mg/kg.6 Chemical Immobilization of Wild and Exotic Animals. (Nielsen, 1999) recommends both the ketamine-xylazine and tiletamine-zolazepam combinations, as well as an option of medetomidine in dosages of 0.04—0.06 mg/kg combined with 2.5—4 mg/kg of xylazine.7
1Flyger, V. M. et. al. 1967. Capturing and handling polar bears: a progress report on polar bear ecological research. Transactions of the North American Wildlife Conference, 32: 107–19.
2Stirling, I. (1986). Research and management of polar bears Ursus maritimus. Polar Record, 23(143), 167-176.
3fws.gov.
4Haigh, J.C., et. al. 1985 Immobilization of polar bears with a mixture of tiletamine hydrochloride and zolazepam hydrochloride. Journal of Wildlife Diseases, 21 :43–47.
5Lee., J., et. al. Immobilization of Polar Bears With Ketamine Hydrochloride and Xylazine Hydrochloride. Journal of Wildlife Diseases, Vol. 17, No.3, July, 1981, 331.
6Arnemo, J., Kreeger, T. (2018). Handbook of Wildlife Chemical Immobilization 5th Ed.
7Nielsen L. Chemical immobilization of wild and exotic animals. Iowa: Iowa State University Press, 1999; 227-281.
About NexGen Pharmaceuticals
NexGen Pharmaceuticals is an industry-leading veterinary compounding pharmacy, offering sterile and non-sterile compounding services nationwide. Unlike other veterinary compounding pharmacies, NexGen focuses on drugs that are difficult to find or are no longer available due to manufacturer discontinuance or have yet to be offered commercially for veterinary applications, but which still serve a critical need for our customers. We also specialize in wildlife pharmaceuticals, including sedatives and their antagonists, offering many unique options to serve a wide array of zoo animal and wildlife immobilization and anesthesia requirements.
Our pharmacists are also encouraged to develop strong working relationships with our veterinarians in order to better care for veterinary patients. Such relationships foster an ever-increasing knowledge base upon which pharmacists and veterinarians can draw, making both significantly more effective in their professional roles.
Disclaimer
The information contained in this blog post is general in nature and is intended for use as an informational aid. It does not cover all possible uses, actions, precautions, side effects, or interactions of the medications shown, nor is the information intended as medical advice or diagnosis for individual health problems or for making an evaluation as to the risks and benefits of using a particular medication. You should consult your veterinarian about diagnosis and treatment of any health problems. Information and statements have not been evaluated by the Food and Drug Administration ("FDA"), nor has the FDA approved the medications to diagnose, cure or prevent disease. Medications compounded by NexGen Pharmaceuticals are prepared at the direction of a veterinarian. NexGen Pharmaceuticals compounded veterinary preparations are not intended for use in food and food-producing animals.
NexGen Pharmaceuticals, LLC does not recommend, endorse or make any representation about the efficacy, appropriateness or suitability of any specific dosing, products, procedures, treatments, services, opinions, veterinary care providers or other information that may be contained in this blog post. NEXGEN PHARMACEUTICALS, LLC IS NOT RESPONSIBLE NOR LIABLE FOR ANY ADVICE, COURSE OF TREATMENT, DIAGNOSIS OR ANY OTHER INFORMATION, SERVICES OR PRODUCTS THAT YOU OBTAIN THROUGH THIS BLOG POST.